Question 1

What are the potential side effects of SU011248?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. clinical trial (NCT00077974). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. clinical trial (NCT00077974). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. clinical trial (NCT00077974). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. clinical trial (NCT00077974). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any travel requirements for attending appointments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. clinical trial (NCT00077974). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if my cancer progresses while on this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. clinical trial (NCT00077974). Contact the study team or your healthcare provider for specific answers.

What this study is about